Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cidara Therapeutics Inc. (CDTX)

  • Business News
  • Oct. 28, 2025, 12:00 UTC
  • 13
  • 0 comments

Cidara Therapeutics to Participate in November Investor Conferences

Market reaction Comment Full text

BioNTech SE (BNTX)

  • Business News
  • Oct. 28, 2025, 11:45 UTC
  • 10
  • 0 comments

BioNTech to Host Innovation Series R&D Day on November 11, 2025

Market reaction Comment Full text

BioNTech SE (BNTX)

  • Business News
  • Oct. 28, 2025, 11:45 UTC
  • 10
  • 0 comments

BioNTech veranstaltet am 11. November 2025 „Innovation Series Day“ zu Forschung & Entwicklung

Market reaction Comment Full text

Edesa Biotech Inc (EDSA)

  • Business News
  • Oct. 28, 2025, 11:45 UTC
  • 8
  • 0 comments

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

Market reaction Comment Full text

Accuray Incorporated (ARAY)

  • Business News
  • Oct. 28, 2025, 11:35 UTC
  • 9
  • 0 comments

Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

Market reaction Comment Full text

Alto Neuroscience Inc. (ANRO)

  • Business News
  • Oct. 28, 2025, 11:34 UTC
  • 9
  • 0 comments

Alto Neuroscience to Participate in Upcoming Investor Conferences

Market reaction Comment Full text

Cronos Group Inc (CRON)

  • Business News
  • Oct. 28, 2025, 11:30 UTC
  • 9
  • 0 comments

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season

Market reaction Comment Full text

Kiniksa Pharmaceuticals (KNSA)

  • Business News
  • Oct. 28, 2025, 11:30 UTC
  • 9
  • 0 comments

Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution

Market reaction Comment Full text

TG Therapeutics Inc. (TGTX)

  • Business News
  • Oct. 28, 2025, 11:30 UTC
  • 9
  • 0 comments

TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI

Market reaction Comment Full text

Repligen Corporation (RGEN)

  • Business News
  • Oct. 28, 2025, 11:30 UTC
  • 8
  • 0 comments

Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Market reaction Comment Full text
  • Previous
  • 105
  • 106
  • 107
  • 108
  • 109
  • Next

Search

News categories

  • Technical Exchange News(10333)
  • Event(1524)
  • SEC News(176357)
  • FDA Approval(9669)
  • Company Report(721)
  • Business News(118167)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin